Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.7 USD | -0.80% | 0.00% | +594.60% |
05-14 | Stephens Starts Elevation Oncology With Overweight Rating, $8 Price Target | MT |
05-02 | Elevation Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+594.60% | 204M | |
+10.05% | 114B | |
+12.86% | 107B | |
-5.63% | 22.22B | |
-0.67% | 21.28B | |
-4.64% | 18.8B | |
-6.54% | 17.51B | |
-39.36% | 17.17B | |
+6.93% | 14.14B | |
+34.08% | 12.2B |
- Stock Market
- Equities
- ELEV Stock
- News Elevation Oncology, Inc.
- JPMorgan Downgrades Elevation Oncology to Neutral from Overweight